GT200500250A - Hexadecasacaridos biotinilados, su preparacion y su utilizacion - Google Patents

Hexadecasacaridos biotinilados, su preparacion y su utilizacion

Info

Publication number
GT200500250A
GT200500250A GT200500250A GT200500250A GT200500250A GT 200500250 A GT200500250 A GT 200500250A GT 200500250 A GT200500250 A GT 200500250A GT 200500250 A GT200500250 A GT 200500250A GT 200500250 A GT200500250 A GT 200500250A
Authority
GT
Guatemala
Prior art keywords
preparation
hexadecasacaridos
biotinilados
hexadecasacarids
anthromromboth
Prior art date
Application number
GT200500250A
Other languages
English (en)
Inventor
Philippe Duchaussoy
Jean Pascal Herault
Jean Marc Herbert
Maurice Petitou
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200500250(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of GT200500250A publication Critical patent/GT200500250A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN DESCRIBE LA PREPARACIÓN Y UTILIZACIÓN DE NUEVOS HEXADECASACARIDOS BIOTINILADOS DE LA FÓRMULA GENERAL I CON LA ACTIVIDAD FARMACOLÓGICA ANTICOAGULANTE Y ANTITROMBÓTICA DE LA HEPARINA.
GT200500250A 2004-09-09 2005-09-08 Hexadecasacaridos biotinilados, su preparacion y su utilizacion GT200500250A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Publications (1)

Publication Number Publication Date
GT200500250A true GT200500250A (es) 2006-04-10

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500250A GT200500250A (es) 2004-09-09 2005-09-08 Hexadecasacaridos biotinilados, su preparacion y su utilizacion

Country Status (39)

Country Link
US (3) US20070270342A1 (es)
EP (1) EP1791872B1 (es)
JP (1) JP5108519B2 (es)
KR (1) KR101223364B1 (es)
CN (1) CN101039963B (es)
AR (1) AR051286A1 (es)
AT (1) ATE420118T1 (es)
AU (1) AU2005284080B2 (es)
BR (1) BRPI0515078A (es)
CA (1) CA2577258C (es)
CY (1) CY1109126T1 (es)
DE (1) DE602005012287D1 (es)
DK (1) DK1791872T3 (es)
EA (1) EA012587B1 (es)
EC (1) ECSP077272A (es)
ES (1) ES2320576T3 (es)
FR (1) FR2874924B1 (es)
GT (1) GT200500250A (es)
HK (1) HK1113686A1 (es)
HN (1) HN2005000518A (es)
HR (1) HRP20090180T1 (es)
IL (1) IL181569A (es)
MA (1) MA28859B1 (es)
MX (1) MX2007002875A (es)
MY (1) MY140666A (es)
NI (1) NI200700063A (es)
NO (1) NO20071754L (es)
PA (1) PA8644201A1 (es)
PE (1) PE20060663A1 (es)
PL (1) PL1791872T3 (es)
PT (1) PT1791872E (es)
RS (1) RS50762B (es)
SI (1) SI1791872T1 (es)
SV (1) SV2006002221A (es)
TN (1) TNSN07053A1 (es)
TW (1) TW200612970A (es)
UY (1) UY29102A1 (es)
WO (1) WO2006030104A1 (es)
ZA (1) ZA200702255B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
EA012587B1 (ru) 2009-10-30
SV2006002221A (es) 2006-01-13
WO2006030104A1 (fr) 2006-03-23
MX2007002875A (es) 2007-05-16
IL181569A (en) 2011-08-31
US8557968B2 (en) 2013-10-15
NI200700063A (es) 2008-03-07
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
ECSP077272A (es) 2007-03-29
CN101039963B (zh) 2011-07-27
EP1791872A1 (fr) 2007-06-06
UY29102A1 (es) 2006-04-28
EA200700594A1 (ru) 2007-08-31
CN101039963A (zh) 2007-09-19
TNSN07053A1 (fr) 2008-06-02
ES2320576T3 (es) 2009-05-25
US20130004551A1 (en) 2013-01-03
KR101223364B1 (ko) 2013-01-16
US20100279960A1 (en) 2010-11-04
EP1791872B1 (fr) 2009-01-07
AU2005284080A1 (en) 2006-03-23
PT1791872E (pt) 2009-03-27
FR2874924B1 (fr) 2006-12-01
AR051286A1 (es) 2007-01-03
JP5108519B2 (ja) 2012-12-26
JP2008512538A (ja) 2008-04-24
MA28859B1 (fr) 2007-09-03
DK1791872T3 (da) 2009-05-04
IL181569A0 (en) 2007-07-04
BRPI0515078A (pt) 2008-07-01
HRP20090180T1 (en) 2009-05-31
NO20071754L (no) 2007-04-02
CA2577258C (fr) 2013-05-21
CA2577258A1 (fr) 2006-03-23
HK1113686A1 (en) 2008-10-10
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
PE20060663A1 (es) 2006-08-21
US20070270342A1 (en) 2007-11-22
SI1791872T1 (sl) 2009-06-30
PL1791872T3 (pl) 2009-06-30
US8703738B2 (en) 2014-04-22
PA8644201A1 (es) 2006-05-16
CY1109126T1 (el) 2014-07-02
AU2005284080B2 (en) 2011-10-13
ATE420118T1 (de) 2009-01-15
KR20070051887A (ko) 2007-05-18
TW200612970A (en) 2006-05-01
HN2005000518A (es) 2009-06-01
MY140666A (en) 2010-01-15

Similar Documents

Publication Publication Date Title
DE602006010132D1 (de) Zwischenprodukte für die Herstellung von Trans-5-Chlor-2-Methyl-2,3,3a,12b-Tetrahydro-1h-DibenzÄ2,3:6,7ÜOxepinoÄ4,5-cÜPyrrol
DE602007004999D1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen-derivate als orexinrezeptor-antagonisten
GT200500250A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion
FR2898636B1 (fr) Structure de queue-d'aronde de soufflante.
UY29109A1 (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
RU2005111873A (ru) Средство с антикоагулянтной, антитромбоцитарной, антитромботической фибриндеполимеризационной и фибринолитической активностями
AR052133A1 (es) Prevencion de infecciones verticales con endoparasitos
DK1713438T3 (da) Medicinsk sæbe
GT200600449A (es) Compuestos de tetrahidro-pirrolizinona farmacéuticamente activos
ITRM20040607A1 (it) Analoghi della dermorfina ad attivita' analgesica.
ITRM20050611A1 (it) Derivati azanucleosidici ad attivita' antivirale.
RU2008136668A (ru) Пептиды, обладающие нейротропной активностью
BRPI0418466B1 (pt) conjunto de assentos de aeronave e aeronave.
FR2864956B1 (fr) Compose derive de 1,3-diphenylprop-2-en-1-one, preparation et utilisations
ITMI20041734A1 (it) Struttura di lattina per bibite, ad elevata funzionalita' di impiego.
ITMO20050231A1 (it) Procedimento e manufatto da rivestimento ottenibile con il procedimento
FI20041385A (fi) Symmetria-akselin määrittäminen
RU2008115714A (ru) Ингибитор 8-оксогуанин-днк-гликозилазы человека
AU305992S (en) Cap
EA200401037A1 (ru) Антифосфолипазный препарат
HN2002000177A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso.
RU2004132147A (ru) Адаптоген
AU308285S (en) Navigation system
AU308000S (en) Navigation system